![Marc Guëll](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc Guëll active positions
Companies | Position | Start | End |
---|---|---|---|
S-Biomedic NV
![]() S-Biomedic NV Household/Personal CareConsumer Non-Durables Part of maxingvest AG, S-Biomedic NV is a Belgian company that develops skin microbiome manipulation technology which allows to transplant beneficial bacteria on the skin. The company is based in Beerse, Belgium. The company was founded in 2014 by Bernhard Päetzold, Veronika Oudova, Marc Guëll. Veronika Oudova has been the CEO since 2014. S-Biomedic was acquired by Beiersdorf AG on December 16, 2022. | Founder | 2013-12-31 | - |
Corporate Officer/Principal | 2013-12-31 | - |
Career history of Marc Guëll
Former positions of Marc Guëll
Companies | Position | Start | End |
---|---|---|---|
eGenesis, Inc.
![]() eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Founder | 2014-12-31 | - |
Statistics
International
United States | 2 |
Belgium | 2 |
Operational
Founder | 2 |
Corporate Officer/Principal | 1 |
Sectoral
Commercial Services | 2 |
Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
eGenesis, Inc.
![]() eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Commercial Services |
S-Biomedic NV
![]() S-Biomedic NV Household/Personal CareConsumer Non-Durables Part of maxingvest AG, S-Biomedic NV is a Belgian company that develops skin microbiome manipulation technology which allows to transplant beneficial bacteria on the skin. The company is based in Beerse, Belgium. The company was founded in 2014 by Bernhard Päetzold, Veronika Oudova, Marc Guëll. Veronika Oudova has been the CEO since 2014. S-Biomedic was acquired by Beiersdorf AG on December 16, 2022. | Consumer Non-Durables |
- Stock Market
- Insiders
- Marc Guëll
- Experience